GovIntel / TX / CHRYSALIS BIOTHERAPEUTICS, INC.

CHRYSALIS BIOTHERAPEUTICS, INC.

Government contractor · Galveston, TX

1
Federal awards
$13.0M
Total awarded
1
Agencies
UEIXW1VFGGRLDW3
CAGE5DAY4
SizeSmall business
SAM statusActive
Established2009

About CHRYSALIS BIOTHERAPEUTICS, INC.

Chrysalis BioTherapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of treatments for serious respiratory disorders and acute radiation exposure. The company is pioneering the use of natural regenerative peptides to restore vascular function and activate stem cells.

Development of TP508 peptide technology for vascular regeneration and tissue repairTreatment of acute respiratory distress syndrome (ARDS) and radiation-induced injuriesPreclinical and clinical research in brain cancer radiation therapy, traumatic brain injury, and nuclear radiation exposureFDA IND application for Phase I human clinical trials for TP508

Recent Federal Awards

AwardAgencyAmountDate
Federal contract awardDepartment of Health and Human Services$13.0M

Is this your company?

Claim CHRYSALIS BIOTHERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim CHRYSALIS BIOTHERAPEUTICS, INC. & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.